
# 2023-09-30
## Modulation of JAK-STAT Signaling by LNK: A Forgotten Oncogenic Pathway in Hormone Receptor-Positive Breast Cancer
## （LNK对JAK-STAT信号传导的调节：激素受体阳性乳腺癌中被遗忘的致癌途径）
## https://www.mdpi.com/1422-0067/24/19/14777
- Breast cancer remains the most frequently diagnosed cancer in women worldwide. Tumors that express hormone receptors account for 75% of all cases. Understanding alternative signaling cascades is important for finding new therapeutic targets for hormone receptor-positive breast cancer patients. JAK-STAT signaling is commonly activated in hormone receptor-positive breast tumors, inducing inflammation, proliferation, migration, and treatment resistance in cancer cells. In hormone receptor-positive breast cancer, the JAK-STAT cascade is stimulated by hormones and cytokines, such as prolactin and IL-6. In normal cells, JAK-STAT is inhibited by the action of the adaptor protein, LNK. However, the role of LNK in breast tumors is not fully understood. This review compiles published reports on the expression and activation of the JAK-STAT pathway by IL-6 and prolactin and potential inhibition of the cascade by LNK in hormone receptor-positive breast cancer. Additionally, it includes analyses of available datasets to determine the level of expression of LNK and various members of the JAK-STAT family for the purpose of establishing associations between expression and clinical outcomes. Together, experimental evidence and in silico studies provide a better understanding of the potential implications of the JAK-STAT-LNK loop in hormone receptor-positive breast cancer progression.
- （乳腺癌仍然是全世界女性最常被诊断出的癌症。表达激素受体的肿瘤占所有病例的75%。了解替代信号级联对于为激素受体阳性乳腺癌患者寻找新的治疗靶点非常重要。JAK-STAT信号传导通常在激素受体阳性乳腺肿瘤中激活，诱导癌细胞的炎症，增殖，迁移和治疗耐药性。在激素受体阳性乳腺癌中，JAK-STAT级联反应受到激素和细胞因子（如催乳素和IL-6）的刺激。在正常细胞中，JAK-STAT受到衔接蛋白LNK的作用的抑制。然而，LNK在乳腺肿瘤中的作用尚不完全清楚。本综述汇编了关于IL-6和催乳素对JAK-STAT通路的表达和激活以及LNK在激素受体阳性乳腺癌中级联反应的潜在抑制的已发表报告。此外，它还包括对可用数据集的分析，以确定LNK和JAK-STAT家族各种成员的表达水平，目的是建立表达与临床结果之间的关联。总之，实验证据和计算机研究提供了对JAK-STAT-LNK环在激素受体阳性乳腺癌进展中的潜在影响更好的理解。）
